Director dealings: Reneuron CFO makes share purchase

dl city of london bank junction underground financial london stock exchange street pb — Sharecast / Kai Pilger via Pixabay

Reneuron revealed on Tuesday that chief financial officer John Hawkins had acquired 100,000 ordinary shares in the AIM-listed stem cell technologies group.

Pharmaceuticals & Biotechnology

19,259.77

15:45 15/11/24

-2.70%

-535.19

ReNeuron Group

3.27p

17:30 05/08/24

-2.96%

-0.10p

Hawkins, who joined Reneuron in October 2014, purchased the shares at an average price of 9.88p each, for a total value of £9,878.

Back in December, Reneuron reported first-half revenues of £440,000, up from £60,000 a year earlier, related to income from partner-funded development activities and royalty income. The company’s loss for the period totalled £3.2m, narrowing from £5.2m, driven by lower costs, increased revenue, and foreign exchange gains.

As of 1610 GMT, Reneuron shares were up 5.75% at 10.42p.

Reporting by Iain Gilbert at Sharecast.com

Top Director Buys

Europa Metals Ltd Npv (di) (EUZ)
Director name: Campion ,Myles Stuart
Amount purchased: 1,090,859 @ 3.35p
Value: £36,543.78

Reneuron Group (RENE)
Director name: Hawkins,John
Amount purchased: 100,000 @ 9.88p
Value: £9,878.00

Europa Metals Ltd Npv (di) (EUZ)
Director name: Kirby,Evan
Amount purchased: 155,129 @ 3.44p
Value: £5,336.44

Murray International Trust (MYI)
Director name: Hardie,David
Amount purchased: 1 @ 1,304.64p
Value: £13.05